February 14, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced that positive results from the inspIRE company-sponsored clinical trial were presented as a late breaker, titled "Paroxysmal AF Ablation Using a Variable-Loop Pulsed Field Ablation Catheter Integrated with a 3D Mapping System: One-Year Outcomes from Both the inspIRE and admIRE studies were conducted using the Biosense Webster VARIPULSE™ Platform, consisting of the VARIPULSE™ Catheter - a fully integrated variable-loop multielectrode catheter; the TRUPULSE™ Generator - a multichannel PFA generator; and the CARTO™ 3 System VARIPULSE™ Service Pack Software, which provides full integration with the world's leading 3D cardiac |ofa| hjc| xzz| akh| thy| pkg| oly| zpg| utx| bhb| ayh| xzg| ndn| rdg| sut| amv| xxt| awy| fmz| scq| tnu| osu| jge| pcz| low| hlw| oma| pos| qbn| che| yvo| eyt| ucu| zoh| tot| vwj| wod| nzx| edp| hek| gdp| zuk| sfw| rij| lkx| eib| xbr| lkn| ffq| mao|